Latest Retained earnings Stories

Net Sales up 31.1% Year-Over-Year and Generates Operating Income DANIA BEACH, Fla., May 15, 2013 /PRNewswire/ -- Vapor Corp. (OTCQB: VPCO; "Vapor" or the "Company"), a leading U.S. based electronic cigarette company whose brands include Krave®, Fifty-One®, VaporX®, Alternacig®, EZ Smoker®, Green Puffer®, Americig®, Fumare(TM), Hookah Stix(TM) and Smoke Star®, today announced its financial results for the first quarter ended March 31, 2013. Financial Highlights for the first...

NEPTUNE, N.J., May 15, 2013 /PRNewswire/ -- Sterling Consolidated Corp. (OTCBB: STCC), a leading supplier of hydraulic and pneumatic seals to the automotive and industrial marketplace, today reported its results for the first quarter ended March 31, 2013. Key Highlights: Filed a Form S-1 to become a publicly traded company on the Over-The-Counter Bulletin Board market as of March 11, 2013 STCC has been profitable quarter over quarter since 2009 Significantly improved Accounts...

Q1 2013 Revenues Increased Over 450% Compared to Q1 2012 MINNEAPOLIS, May 15, 2013 /PRNewswire/ -- BioDrain Medical, Inc. (OTCQB: BIOR) (the "Company"), producer of the FDA approved STREAMWAY((TM)) System for automated, direct-to-drain surgical fluid disposal that reduces the risk of exposure to hazardous waste, today reported its results for the first quarter ended March 31, 2013. Key Highlights: Revenues of $127,727 for Q1 2013 were up over 450% compared to Q1 2012 Sales to...

SOUTH SAN FRANCISCO, Calif., May 14, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq:KBIO) a biopharmaceutical company with a portfolio of patient-targeted, first-in-class, antibodies to treat serious medical conditions with a primary clinical focus on respiratory diseases and cancer, announced today its financial results for the first quarter ended March 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO) "KaloBios marked the first quarter of 2013...

RICHARDSON, Texas, May 13, 2013 /PRNewswire/ -- Intrusion Inc. (OTCBB: INTZ), ("Intrusion") today announced financial results for the quarter ended March 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20030703/INTRUSIONLOGO) Intrusion's net income was $57 thousand in the first quarter 2013, compared to a net loss of $352 thousand for the first quarter 2012. Revenue for the first quarter 2013 was $1.78 million, compared to $1.40 million for the first quarter 2012. Gross...

NEWTON, Mass., May 13, 2013 /PRNewswire/ -- Ambient Corporation (NASDAQ: AMBT), provider of a secure, flexible, and scalable smart grid platform, announced today financial results for the first quarter ended March 31, 2013, and its plans to reduce its operating expenses, primarily through a reduction in its workforce and compensation reductions to senior management. (Logo: http://photos.prnewswire.com/prnh/20090311/AMBIENTLOGO ) Total revenue for the first quarter of 2013 was...

ST. LOUIS, May 10, 2013 /PRNewswire/ -- The continuing recession in domestic hospital equipment and a dip in international sales resulted in a loss for Allied Healthcare Products (NASDAQ: AHPI) in its third quarter of fiscal year 2013. Net loss for the quarter ending March 31, 2013, was about $280,000, or a negative 3 cents per basic and diluted share, versus a loss of about $146,000, or a negative 2 cents per basic and diluted share, for the prior year. Sales for the third quarter...

PHILADELPHIA, May 10, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony(®) CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31, 2013. Echo's Quarterly Report on Form 10-Q, as filed with the SEC, will be available by visiting the Investors section of Echo's website at www.echotx.com. (Logo:...

Company to Hold Conference Call on Thursday, May 9, 2013 at 11:00 a.m. ET LAWRENCEVILLE, N.J., May 9, 2013 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the first quarter ended March 31, 2013 and provided a business update on its clinical trials of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin. ThermoDox® is being evaluated in a global, multi-center Phase III...

MELBOURNE, Fla., May 9, 2013 /PRNewswire/ -- The Goldfield Corporation (NYSE MKT: GV) today announced improved revenue and operating income for the three months ended March 31, 2013. The Goldfield Corporation headquartered in Florida, through its subsidiary, Southeast Power Corporation, is a leading provider of construction services to electric utilities, with operations primarily in the southeastern, mid-Atlantic, and western regions of the United States. Revenue for the three...